Last Price
55.00
Today's Change
+4.00 (7.84%)
Day's Change
49.00 - 55.00
Trading Volume
20,755
Profile
FARN
Exchange: London Stock Exchange London Stock Exchange
Currency: GBp GBp
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Juho Markku Jalkanen Juho Markku Jalkanen
Full Time Employees: 25 25
IPO Date: 2015-11-17 2015-11-17
Description
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. The company also develops Haematokine, a new chemical entity AOC3 inhibitor for the treatment of hematological malignancies and bone marrow. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.
Address
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now